Skip to content
Advertisement

This image provided by Sanofi shows a box containing two single-dose pre-filled syringes of the drug Dupixent. On Tuesday, March 28, 2017, the Food and Drug Administration approved Dupixent for moderate or severe eczema, which causes red, fiercely itchy rashes on the face, arms and legs. (Rodrigo Cid/Sanofi via AP)

This image provided by Sanofi shows a box containing two single-dose pre-filled syringes of the drug Dupixent. On Tuesday, March 28, 2017, the Food and Drug Administration approved Dupixent for moderate or severe eczema, which causes red, fiercely itchy rashes on the face, arms and legs. (Rodrigo Cid/Sanofi via AP)

Featured Photo Galleries